# Oral Dosage Form New Animal Drugs; Trilostane
> **Food and Drug Administration** · Final rule. · Published 2009-06-26 · Effective 2009-06-26 · 74 FR 30463
## Document
- **Document number:** E9-15152
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 74 FR 30463
- **CFR reference:** 21 CFR 520
- **Publication date:** 2009-06-26
- **Effective date:** 2009-06-26
- **HHS docket:** Docket No. FDA-2009-N-0665
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the supplemental approval of a new animal drug application (NADA) filed by Dechra, Ltd. The supplemental NADA provides for the addition of a 10-milligram capsule size of trilostane, used in dogs for treatment of hyperadrenocorticism.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2009/06/26/E9-15152/oral-dosage-form-new-animal-drugs-trilostane)
---
*AI Analytics · CC0 1.0*